ARCI backs enhanced NSAID and corticosteroid regs
Following a meeting on Monday, Aug. 5, the Drug Testing Standards and Practices (DTSP) Committee of the Association of Racing Commissions International (ARCI) endorsed instituting a 48-hour restriction on administration of nonsteroidal anti-inflammatory drugs (NSAIDS), which include Phenylbutazone, and a 14-day restriction on the administration of corticosteroids, pending scientific review.
The restriction on corticosteroids would not apply to harness racing, as the sport is currently amidst proceedings to determine breed-specific rules due to different race schedules for Thoroughbreds, Standardbreds and Quarter Horses.
The corticosteroids were previously included in the Model Rules but were removed per the instructions of the Racing Medication & Testing Consortium (RMTC). In a recent meeting of the RMTC, that organization recommended the 48-hour restriction on NSAIDs as the science is available to prove administration after that window can compromise a pre-race examination.
“There have been situations, specifically in New York, where these restrictions have been implemented and been quite successful,” said Ed Martin, ARCI president and past executive director of the New York Gaming and Wagering Board.
LATEST BUSINESS NEWS
The 50th annual Eclipse Awards will be a virtual event this year, held January 28.
The Maryland Racing Commission today gave its final thumbs-up to a regulation banning the use of Lasix by horses in graded stakes.
Keith Jones, the racecaller at Parx Racing for over 30 years, will retire at the end of 2020.
Hall of Fame trainer Jonathan Sheppard is, for the first time, sending a string of jumpers to Ireland to compete there and in England.
Applications are now open for the 2021 competition year of the Thoroughbred Makeover and National Symposium.
With the Covid-19 pandemic having a major impact, claiming activity in the Mid-Atlantic region is off by more than 30% this year versus last.